BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 33649193)

  • 1. Genomically Complex Human Angiosarcoma and Canine Hemangiosarcoma Establish Convergent Angiogenic Transcriptional Programs Driven by Novel Gene Fusions.
    Kim JH; Megquier K; Thomas R; Sarver AL; Song JM; Kim YT; Cheng N; Schulte AJ; Linden MA; Murugan P; Oseth L; Forster CL; Elvers I; Swofford R; Turner-Maier J; Karlsson EK; Breen M; Lindblad-Toh K; Modiano JF
    Mol Cancer Res; 2021 May; 19(5):847-861. PubMed ID: 33649193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Genomics Reveals Shared Mutational Landscape in Canine Hemangiosarcoma and Human Angiosarcoma.
    Megquier K; Turner-Maier J; Swofford R; Kim JH; Sarver AL; Wang C; Sakthikumar S; Johnson J; Koltookian M; Lewellen M; Scott MC; Schulte AJ; Borst L; Tonomura N; Alfoldi J; Painter C; Thomas R; Karlsson EK; Breen M; Modiano JF; Elvers I; Lindblad-Toh K
    Mol Cancer Res; 2019 Dec; 17(12):2410-2421. PubMed ID: 31570656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Machine learning application identifies novel gene signatures from transcriptomic data of spontaneous canine hemangiosarcoma.
    Cheng N; Schulte AJ; Santosa F; Kim JH
    Brief Bioinform; 2021 Jul; 22(4):. PubMed ID: 33078825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Actionable mutations in canine hemangiosarcoma.
    Wang G; Wu M; Maloneyhuss MA; Wojcik J; Durham AC; Mason NJ; Roth DB
    PLoS One; 2017; 12(11):e0188667. PubMed ID: 29190660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression profiles of sporadic canine hemangiosarcoma are uniquely associated with breed.
    Tamburini BA; Trapp S; Phang TL; Schappa JT; Hunter LE; Modiano JF
    PLoS One; 2009 May; 4(5):e5549. PubMed ID: 19461996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular subtypes in canine hemangiosarcoma reveal similarities with human angiosarcoma.
    Wang G; Wu M; Durham AC; Radaelli E; Mason NJ; Xu X; Roth DB
    PLoS One; 2020; 15(3):e0229728. PubMed ID: 32210430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic profiling reveals extensive heterogeneity in somatic DNA copy number aberrations of canine hemangiosarcoma.
    Thomas R; Borst L; Rotroff D; Motsinger-Reif A; Lindblad-Toh K; Modiano JF; Breen M
    Chromosome Res; 2014 Sep; 22(3):305-19. PubMed ID: 24599718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of genomic alterations with clinical impact in canine splenic hemangiosarcoma.
    Estabrooks T; Gurinovich A; Pietruska J; Lewis B; Harvey G; Post G; Lambert L; Miller A; Rodrigues L; White ME; Lopes C; London CA; Megquier K
    Vet Comp Oncol; 2023 Dec; 21(4):623-633. PubMed ID: 37734854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary mammary angiosarcomas harbor frequent mutations in KDR and PIK3CA and show evidence of distinct pathogenesis.
    Beca F; Krings G; Chen YY; Hosfield EM; Vohra P; Sibley RK; Troxell ML; West RB; Allison KH; Bean GR
    Mod Pathol; 2020 Aug; 33(8):1518-1526. PubMed ID: 32123305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the oncogenomic landscape of canine and feline hemangiosarcoma shows novel parallels with human angiosarcoma.
    Wong K; Ludwig L; Krijgsman O; Adams DJ; Wood GA; van der Weyden L
    Dis Model Mech; 2021 Jul; 14(7):. PubMed ID: 34296746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted massively parallel sequencing of angiosarcomas reveals frequent activation of the mitogen activated protein kinase pathway.
    Murali R; Chandramohan R; Möller I; Scholz SL; Berger M; Huberman K; Viale A; Pirun M; Socci ND; Bouvier N; Bauer S; Artl M; Schilling B; Schimming T; Sucker A; Schwindenhammer B; Grabellus F; Speicher MR; Schaller J; Hillen U; Schadendorf D; Mentzel T; Cheng DT; Wiesner T; Griewank KG
    Oncotarget; 2015 Nov; 6(34):36041-52. PubMed ID: 26440310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of the p53 and PIK3CA/AKT/mTOR pathways in angiosarcomas: a pattern distinct from other sarcomas with complex genomics.
    Italiano A; Chen CL; Thomas R; Breen M; Bonnet F; Sevenet N; Longy M; Maki RG; Coindre JM; Antonescu CR
    Cancer; 2012 Dec; 118(23):5878-87. PubMed ID: 22648906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic landscapes of canine splenic angiosarcoma (hemangiosarcoma) contain extensive heterogeneity within and between patients.
    Wong S; Ehrhart EJ; Stewart S; Zismann V; Cawley J; Halperin R; Briones N; Richter K; Sivaprakasam K; Perdigones N; Contente-Cuomo T; Facista S; Trent JM; Murtaza M; Khanna C; Hendricks WPD
    PLoS One; 2022; 17(7):e0264986. PubMed ID: 35867969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta Adrenergic Signaling: A Targetable Regulator of Angiosarcoma and Hemangiosarcoma.
    Dickerson EB; Bryan BA
    Vet Sci; 2015 Sep; 2(3):270-292. PubMed ID: 29061946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PIK3CA mutations matter for cancer in dogs.
    Kim JH
    Res Vet Sci; 2020 Dec; 133():39-41. PubMed ID: 32932196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-214 Promotes Apoptosis in Canine Hemangiosarcoma by Targeting the COP1-p53 Axis.
    Heishima K; Mori T; Sakai H; Sugito N; Murakami M; Yamada N; Akao Y; Maruo K
    PLoS One; 2015; 10(9):e0137361. PubMed ID: 26335793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 is not inactivated in B6C3F1 mouse vascular tumors arising spontaneously or associated with long-term administration of the thiazolidinedione troglitazone.
    Duddy SK; Parker RF; Bleavins MR; Gough AW; Rowse PE; Gorospe S; Dethloff LA; de la Iglesia FA
    Toxicol Appl Pharmacol; 1999 Apr; 156(2):106-12. PubMed ID: 10198275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous and thiazolidinedione-induced B6C3F1 mouse hemangiosarcomas exhibit low ras oncogene mutation frequencies.
    Duddy SK; Gorospe SM; Bleavins MR; de la Iglesia FA
    Toxicol Appl Pharmacol; 1999 Oct; 160(2):133-40. PubMed ID: 10527912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent CIC Gene Abnormalities in Angiosarcomas: A Molecular Study of 120 Cases With Concurrent Investigation of PLCG1, KDR, MYC, and FLT4 Gene Alterations.
    Huang SC; Zhang L; Sung YS; Chen CL; Kao YC; Agaram NP; Singer S; Tap WD; D'Angelo S; Antonescu CR
    Am J Surg Pathol; 2016 May; 40(5):645-55. PubMed ID: 26735859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The genetics of vascular tumours: an update.
    Torrence D; Antonescu CR
    Histopathology; 2022 Jan; 80(1):19-32. PubMed ID: 34958509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.